← SynDRA
TCV-309 cation
SynDRA canonical compound SYN0048053 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PAFAH1B1 | PAFAH1B2 | PAFAH1B3 | PTAFR |
|---|
| Mechanism of action | platelet activating factor receptor antagonist |
|---|
All known targets
- PTAFR
- PAFAH1B1
- PAFAH1B2
- PAFAH1B3
Mechanisms of action (all sources)
- platelet activating factor receptor antagonist
- PTAFR MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- UNII-U32W2WAF3L
- U32W2WAF3L
- TCV-309 ION
- AKOS040749622
- orb1699166
- CS-0014860
- SCHEMBL9051635
- Tcv 309
- RefChem:932626
- AC1L3GRQ
- T28933
- LS-184311
- 2-[3-(N-(2-bromo-1-propylpyridin-1-ium-4-carbonyl)anilino)propanoylamino]ethyl 3,4-dihydro-1H-isoquinoline-2-carboxylate nitrate
- HY-19121
- SMQ997EQ85
- UNII-SMQ997EQ85
- TCV-309
- SCHEMBL29384283
Look up TCV-309 cation in the interactive SynDRA portal →